Petition to Angela Merkel (CDU), G20 leaders, Angela Merkel, Theresa May MP, Mauricio Macri, Malcolm Turnbull, Michel Temer, Justin Trudeau, Xi Jinping, Narendra Modi, Joko Widodo, Paolo Gentiloni, Shinzo Abe, Enrique Peña Nieto, Vladimir Putin, Salman bin Abdulaziz, Jacob Zuma, Recep Tayyip Erdoğan, Donald Trump, Donald Tusk, Jean-Claude Juncker
Global Health Innovation Call to Action
To sign our Call to Action, please click here. This Call to Action strongly urges the G20 to commit investment in research, innovation and development of innovative health technologies to counter threats posed by Antimicrobial Resistance (AMR), Poverty-Related and Neglected Diseases (PRNDs) and pandemics. We call on the G20 to agree to take the following actions: 1. Provide political support to address the inter-related issues of AMR, pandemic preparedness/ response and PRNDs Include a commitment to research and development (R&D) of products and interventions for global health in the outcome document of the Meeting of the G20 Ministers of Health, in the G20 Communiqué and in all relevant G20 agendas, with a focus on addressing the threat of a broad spectrum of emerging antimicrobial resistance from a variety of bacteria, parasites, viruses and fungi, as well as emerging infectious diseases. 2. Increase financial support and its co-ordination across the G20 and partner countries to ensure sustainable, long-term funding for global health innovation, with a focus on AMR, pandemic preparedness/ response and PRNDs. Coordinate funding between G20 countries to ensure inefficiencies and duplication of efforts are avoided, and that the significant costs of product development are shared among nations. 3. Encourage business, philanthropic organizations and other financing institutions from the G20 to increase investment in global health innovation, in the interrelated areas of AMR, pandemic preparedness / response and PRNDs. Promote financial support to the work of multinational partnership mechanisms such as Product Development Partnerships (PDPs) and other public-private collaborations to expand global health innovation. 4. Mobilize G20 public health and scientific expertise to address antimicrobial resistance (AMR) in both neglected and major poverty diseases by: Supporting global efforts to develop new tools, interventions and approaches to address AMR. Assisting low and middle-income G20 partner countries in building up their research and product development capacity for the fight against AMR. Promoting open data sharing in R&D to help technology transfers and strengthening of research capacity in G20 and partner countries to address AMR. We invite all those who share this vision to sign and support this Call to Action In advance of the 2017 Hamburg Summit we would like to commend G20 leaders, and especially the German Presidency, for putting the 2030 Agenda for Sustainable Development and global health at the top of the G20 agenda. We represent a group of like-minded advocates and experts from public and private sector organizations calling on the G20 to commit political and financial resources as well as expertise to science, technology and innovation (STI) in global health. We support the view of Chancellor Merkel that “health is an issue that belongs on the G20 agenda” and her belief that addressing the world’s health challenges should become a permanent agenda item. Medical innovation and the policy changes needed to transform global health take years to develop and take effect, and require long-term political and economic commitment. Looking ahead, the risk of resistance and emerging infectious diseases, combined with increased transnational mobility, poses a major challenge for the global health community. Innovative technologies for the protection of new vulnerable groups, such as migrant populations, are essential components of control, elimination and eradication strategies moving forward. The World Bank has estimated that by 2050, these issues will push an additional 28.3 million people into poverty, increase global healthcare costs by $1.2 trillion and cause low income countries to lose more than 5% GDP. G20 leadership in combatting neglected diseases could lead to significant reductions in the global disease burden, lifting millions out of poverty and averting billions of dollars of economic and social costs.